Clinical Trial Update: Gefitinib Versus Pemetrexed for Previously Treated NSCLC Patients [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing gefitinib with pemetrexed in patients with previously treated metastatic non-small cell lung cancer has completed enrollmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gefitinib (Gefitinib)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Previous Treated Metastatic Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED